Skip to main content
European Network of Centres for Pharmacoepidemiology and Pharmacovigilance
News article16 April 2012European Medicines Agency1 min read

Notice of Call for Expressions of Interest for Drug Safety Studies

The validity of the shortlist which was established via Call for Expressions of Interest ref. EMEA/2009/62/PHP will expire in July 2012. The European Medicines Agency (EMA) has therefore launched a new Call for Expressions of Interest with a view to drawing up a list of potential contractors who may be invited to reply to specific invitations to tender in the future. The purpose of this call is to enable the EMA to obtain fast and reliable answers to questions on safety or benefit:risk concerns, and ultimately facilitating regulatory decision-making. The scope of the funding is not restricted to research into the safety of centrally authorised products. The estimated budget per study will be between €50,000 and €130,000.

Applications may be submitted anytime before 2 January 2015. The shortlist arising from this procedure will be valid until 2 April 2015.

Related information:

- Notice of Call for Expressions of Interest ref. EMA/2012/08/CN

 

Details

Publication date
16 April 2012
Author
European Medicines Agency